| Basics |
Pacific Biosciences of California, Inc.
Pacific Biosciences of California Inc is a biotechnology company. It is engaged in design, development, and manufacture of sequencing system to help scientists resolve genetically complex problems.
|
| IPO Date: |
October 27, 2010 |
| Sector: |
Healthcare |
| Industry: |
Medical Diagnostics and Research |
| Market Cap: |
$432.12M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.25 | 3.22%
|
| Avg Daily Range (30 D): |
$0.06 | 4.20%
|
| Avg Daily Range (90 D): |
$0.05 | 3.99%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
2.55M |
| Avg Daily Volume (30 D): |
9.36M |
| Avg Daily Volume (90 D): |
8.45M |
| Trade Size |
| Avg Trade Size (Sh.): |
188 |
| Avg Trade Size (Sh.) (30 D): |
668 |
| Avg Trade Size (Sh.) (90 D): |
561 |
| Institutional Trades |
| Total Inst.Trades: |
4,282 |
| Avg Inst. Trade: |
$2.2M |
| Avg Inst. Trade (30 D): |
$.79M |
| Avg Inst. Trade (90 D): |
$1.03M |
| Avg Inst. Trade Volume: |
.23M |
| Avg Inst. Trades (Per Day): |
2 |
| Market Closing Trades |
| Avg Closing Trade: |
$3.42M |
| Avg Closing Trade (30 D): |
$.81M |
| Avg Closing Trade (90 D): |
$1.16M |
| Avg Closing Volume: |
336.84K |
|
|
| Financials |
| |
TTM |
Q1 2025 |
Q4 2024 |
|
Basic EPS
|
$-2.28
|
$-1.44
|
$.02
|
|
Diluted EPS
|
$-2.74
|
$-1.44
|
$-.44
|
|
Revenue
|
$ 152.36M
|
$ 37.15M
|
$ 39.22M
|
|
Gross Profit
|
$ 24.63M
|
$ -1.37M
|
$ 10.06M
|
|
Net Income / Loss
|
$ -657.75M
|
$ -426.08M
|
$ 2.37M
|
|
Operating Income / Loss
|
$ -821.89M
|
$ -428.93M
|
$ -153.03M
|
|
Cost of Revenue
|
$ 127.73M
|
$ 38.52M
|
$ 29.17M
|
|
Net Cash Flow
|
$ -18.64M
|
$ 3.14M
|
$ -22.61M
|
|
PE Ratio
|
|
|
|
|
|
|
